Jorgensen Nathan D. 4

4 · Voyager Therapeutics, Inc. · Filed Feb 26, 2026

AI-generated summary of this filing

Updated Feb 26, 2026

Voyager Therapeutics CFO Nathan D. Jorgensen Sells 4,668 Shares

What Happened

Nathan D. Jorgensen, Chief Financial Officer of Voyager Therapeutics (VYGR), disposed of 4,668 shares on February 24, 2026. The weighted average sale price was $3.77 per share, for total proceeds of approximately $17,598.
This was a sale (not a purchase) and was executed as a sell‑to‑cover to satisfy tax withholding related to restricted stock units that vested on February 21, 2026. The filing notes the sales were not discretionary.

Key Details

Transaction date: 2026-02-24; Form 4 filed: 2026-02-26 (timely).
Price: weighted average $3.77; individual sale prices ranged from $3.61 to $3.86.
Shares sold: 4,668; proceeds ≈ $17,598.
Shares owned after the transaction: not specified in the provided filing excerpt.
Footnotes: (1) Sales made pursuant to a durable automatic sale instruction (sell‑to‑cover) adopted May 9, 2025, to satisfy tax withholding for RSU vesting; not a discretionary trade. (2) Weighted average price reported; reporting person will provide per‑price breakdown on request.
Remarks: Exhibit 24.1 (Limited Power of Attorney) attached to the filing.

Context

Sell‑to‑cover transactions are routine tax‑related sales that occur when RSUs vest and the company (or reporting person) sells a portion of the shares to cover taxes; they generally do not indicate an insider’s view on the stock.
The filing shows a routine disposal related to compensation tax withholding rather than an open‑market, discretionary sale intended to express a view on company prospects.

Form 4

Period: 2026-02-24

Chief Financial Officer

Transactions

Footnotes (2)

[F1]Represents shares of common stock of Voyager Therapeutics, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 9, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 21, 2026. The sales do not represent a discretionary trade by the reporting person.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.86, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Signature

/s/ Gregory Shiferman, as Attorney-in-Fact for Nathan D. Jorgensen|2026-02-26

2 files